497 related articles for article (PubMed ID: 6652966)
1. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
Naama JK; Mitchell WS; Whaley K
Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
[TBL] [Abstract][Full Text] [Related]
2. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
Kerr MA; Wilton E; Naama JK; Whaley K
Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
5. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
[TBL] [Abstract][Full Text] [Related]
6. IgM-RF prevents complement-mediated inhibition of immune precipitation.
Mitchell WS; Naama JK; Veitch J; Whaley K
Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
[TBL] [Abstract][Full Text] [Related]
8. Immune complexes and complement in rheumatoid arthritis.
Lambert PH; Casali P; Nydegger U
Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
[TBL] [Abstract][Full Text] [Related]
9. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
Gabriel A; Agnello V
J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
[TBL] [Abstract][Full Text] [Related]
10. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
Schifferli JA; Steiger G; Schapira M
Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
[TBL] [Abstract][Full Text] [Related]
11. Breakdown products of C 3 in human synovial fluids.
Zvaifler NJ
J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
[TBL] [Abstract][Full Text] [Related]
12. Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.
Oleesky DA; Daniels RH; Williams BD; Amos N; Morgan BP
Clin Exp Immunol; 1991 May; 84(2):250-5. PubMed ID: 2025952
[TBL] [Abstract][Full Text] [Related]
13. Complement-fixing material in ther sera of patients with rheumatoid arthritis.
McDuffie FC; Hunder GG; Clark RJ
Clin Exp Immunol; 1978 May; 32(2):218-25. PubMed ID: 668197
[TBL] [Abstract][Full Text] [Related]
14. Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids.
De Bracco MM; Stroud RM; Christian CL
Clin Exp Immunol; 1972 Jun; 11(2):209-18. PubMed ID: 4625157
[TBL] [Abstract][Full Text] [Related]
15. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
[TBL] [Abstract][Full Text] [Related]
17. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
Baatrup G; Petersen I; Jensenius JC; Svehag SE
Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of expontaneous cytotoxicity and antibody dependency by rheumatoid synovial fluid].
Noguera Hernando E; Kreisler M; Durantez A; Larrea Gayarre A; de Landazuri MO; Cruz MartÃnez J
Allergol Immunopathol (Madr); 1978; 6(3):253-62. PubMed ID: 717203
[TBL] [Abstract][Full Text] [Related]
19. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
[TBL] [Abstract][Full Text] [Related]
20. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]